José María Frade
José María Frade is a prominent researcher at the Cajal Institute of the Spanish National Research Council (CSIC) in Madrid, known for his groundbreaking work on the development of the nervous system in embryos. His innovative research on the role of the E2F4 transcription factor in neuron cell cycles has opened new avenues for understanding and potentially treating neurodegenerative diseases like Alzheimer's. Frade's insights led to the founding of Tetraneuron, a company that aims to develop a novel gene therapy targeting Alzheimer's by preventing the reactivation of neuronal cell cycles, thus preserving neuronal health.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Colombia:
Neurobiologist José María Frade's research at the Instituto Cajal has led to the development of a strategy based on modifying the transcription factor E2F4.
8
Spain:
José María Frade is an investigator at the Cajal Institute of CSIC in Madrid who has been studying the development of the nervous system in embryos.
8